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Abstract
Endometriosis is one of the most common gynecological diseases in the world 
with a great variety of symptoms and clinical features. The true prevalence rates in 
the general population are not known, but according to different authors, endome-
triosis is to be found in 10% in women of reproductive age. According to different 
publications, around half of the patients with infertility were diagnosed with 
endometriosis which change the significance of this disease from the only female to 
a socio-economical problem. In this chapter, we will focus on the current view on 
endometriosis-associated infertility, from superficial to adenomyosis, with a closer 
view of surgical treatment, as it is still the standard of care for diagnosis and in 
severe cases—treatment of the disease.
Keywords: adenomyosis, DIE, deep infiltrative endometriosis, endometrioma, 
peritoneal endometriosis, infertility, IVF
1. Introduction
Today, the medical community considers endometriosis as a significant disease and 
problem. According to different resources, about 176 million women are suffering from 
the disease worldwide. In multination, multicenter study [1] about 50% of gynecolo-
gists polled in Russia in 2007 examined 7–28 patients with endometriosis per month 
(240 patients per year). The number was almost equal to that of patients with myoma.
Endometriosis is known to be found in 60% of women aged under 30. More 
important is the fact that there is a 7-year delay from the first disease manifestation 
to the diagnosis [2].
The physician should suspect the endometriosis if the following complaints are 
present [3]:
• Dysmenorrhea, acyclic pelvic pain, deep dyspareunia, and infertility
• If a woman of reproductive age has the following symptoms: dyschesia, 
dysuria, hematuria, and rectorrhagia
Even though the exact mechanism of endometriosis-associated infertility is still 
unknown, some aspects are well studied. Endometriosis has an influence on the 
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quality of peritoneal fluid with growing macrophage concentration as well as pro-
teases and cytokines negatively influencing the quality of oocytes, sperm, embryo, 
and fallopian tube potential.
It is difficult to recommend the optimal treatment as the development of the 
disease is unpredictable—from asymptomatic to very aggressive though pelvic pain 
and infertility usually called “active endometriosis” [4].
The American Society of Reproductive Medicine (ASRM) classification of 
endometriosis describes four stages of the disease. But that does not always correlate 
with the actual symptoms (pain, infertility, etc.) [5–7]. The more you work with 
this classification, the more it becomes obvious that patients with the same stages 
of the disease by ASRM classification, in fact, are incomparable. The ideal approach 
to endometriosis treatment should take into consideration how active the disease is. 
The “active” disease requires a combined treatment. The combination of surgical, 
hormonal treatment, and in vitro fertilization (IVF) could be individually chosen in 
each specific case of infertile patients.
For an easier understanding of how to treat endometriosis-associated infertility, 
it is better to separate the disease in four different phenotypes: superficial, endome-
trioma, deep infiltrated endometriosis, and adenomyosis.
2. Superficial endometriosis
The “gold” standard of superficial endometriosis treatment is laparoscopy. The 
common indications for surgery are pelvic pains and infertility. Hysteroscopy and 
biopsy, laparoscopy with fallopian tube perturbation, adhesiolysis, endometriosis 
staging with ablation, and/or removal lesions could be recommended. Pregnancy 
rate (PR) after laparoscopic treatment is the same for all stages [5].
However, if pelvic pain dominates, empirical conservative medical treatment 
could be applied. Infertile patients should be informed of alternative methods of 
treatment. Pregnancy can be achieved with IVF without surgery.
Laparoscopic treatment of minimal and mild endometriotic lesions (stage 1 
and 2 ASRM) is justified in the case of pelvic pain because their destruction sig-
nificantly decreases the pain compared with diagnostic laparoscopy alone. In this 
context, ablation and excision give identical results in terms of pain reduction. It 
is not recommended to treat asymptomatic patients. Literature shows no interest 
in uterine nerve ablation in case of dysmenorrhea due to minimal and mild endo-
metriosis. With regard to treatment of minimal and mild endometriosis in infertile 
patients, only two studies can be selected, and both show that laparoscopy with 
excision or ablation and ablation of adhesions is superior to diagnostic laparoscopy 
alone also in terms of pregnancy rate [65].
The effectiveness of adjuvant hormonal treatment after surgery is not improved. 
Most hormonal medications have a contraceptive effect and make spontaneous 
pregnancy almost impossible.
IVF should be recommended in cases of fallopian tubes’ low potential and/or 
male infertility. The spontaneous PR is very low if there are several simultaneous 
infertility factors. The very important factor is also the maternal age. At present, 
there is no generally accepted age for patients who should be recommended to go 
straight to ART after surgery and who could try to achieve spontaneous pregnancy. 
But a lot of surgeons agree that the maternal age of 35 and higher should be consid-
ered in favor of ART after surgery.
de Ziegler’s et al. in the review [67] presented an algorithm for the management 
of infertility associated with endometriosis. This algorithm is presented in Figure 1.
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The repeated surgery is not recommended due to low spontaneous PR. The 
second (third, fourth, etc.) laparoscopy results in further IVF. This is not because 
of the bad surgery performed but because endometriosis is a chronical complex 
disease, which is associated with pelvic inflammation and profound alterations of 
peritoneal fluid, which surrounds the pelvic organs [66]. These alterations could 
affect natural conception.
3. Deep infiltrating endometriosis
Recently, the number of patients with deep infiltrating endometriosis (DIE) 
has been steadily increasing. It is estimated to affect up to 12% of all women with 
endometriosis. DIE is detected in 50–70% of patients of reproductive period with 
pain syndrome. This disease is diagnosed when there is an infiltration of 5 mm or 
more beneath the peritoneal surface [8] and/or an involvement of muscular layer of 
affected organ into the pathologic process is found [9].
DIE is characterized by multifocal distribution with the involvement of peri-
toneum, pelvic spaces, uterus ligaments, rectovaginal septum, vagina, intestine, 
bowel, ureters and bladder, and diaphragm. The feature of such dissemination 
is the lymphovascular invasion, the degree of which one is correlated with sizes 
of the primary endometrioid nodules. It is also estimated that endometriotic 
lesions seem to infiltrate the bowel wall preferentially along the nerves, even at 
distance from palpated nodules, while the mucosa is rarely and only focally 
involved [10].
Figure 1. 
Algorithm for management of infertility associated with endometriosis [67]. IVF, in vitro fertilization; ART, 




There is no correlation between the stage of endometriosis, how deep it is, the 
number of symptoms, and their duration. Infertility is the most frequent symptom. 
Development of infertility in DIE is multifactorial: pelvic adhesions, the decrease 
in ovarian reserve, and a poor quality of oocytes in case of involvement of the 
ovaries. It is assumed that changes in ectopic endometrium are not as pronounced in 
patients with DIE as in cases of severe adenomyosis. This conclusion could be made 
on the basis that in patients with DIE, the frequency of miscarriages is less, and the 
frequency of successful IVF attempts is satisfactory.
In cases of lesions difficult location (myometrium, bowel and ileum, pararectal 
space), where removal is technically impossible or highly risky, the combination 
of surgery and medication is very promising. According to the data of Darai et al., 
spontaneous PR after surgical treatment is 51.1%, whereas IVF PR is 18.9% [20].
The medical treatment of deep infiltrating endometriosis may decrease symp-
toms and is often associated with such side effects as noncyclic bleedings, weight 
increase, libido loss, and headaches. It doesn′t provide the control of disease course 
in a long-term period, and when the treatment is over, the disease progresses. 
Moreover, the medical options have contraceptive effects and can′t be used when 
pregnancy is attempted [11].
Surgical treatment of DIE and infertility in most cases is preferable. 
Spontaneous pregnancy rate (PR) after surgical treatment of DIE is close to 
50% [11]. It means that every second patient with DIE and infertility will not 
require IVF.
At the same time, we must not forget that the rate of severe postoperative 
complications of DIE treatment (rectal bleeding, anastomosis insufficiency, recto-
vaginal fistulas, abscesses, fecal peritonitis) is 10% [12]. Patients must be informed 
about the possible complications and results of DIE infertility treatment. IVF is 
preferable if other symptoms (pain, dyspareunia, dyschezia, low urinary tract 
symptoms) are absent.
There are no doubts about the removal of such endometriotic nodules in 
the bladder and parametrium, but the choice of ideal surgical approach to the 
treatment of bowel endometriosis is more controversial. Three types of surgi-
cal removal of endometrioid nodules are described: shaving, discoid, and bowel 
resection. According to the data of Abrao et al. [13], the treatment algorithm for 
deep endometriosis compromising the bowel must be individualized (Figure 2). 
“Conservative” surgery (shaving) is more appropriate in reproductive medicine due 
to its less risk. Surgery of DIE including bowel resection should be considered as a 
second-line treatment after failed IVF and in cases when there is a presentation of 
such symptoms as pelvic pain, dyspareunia, dyschezia, and bowel stenosis.
We can’t recommend the anticipating spontaneous pregnancy after surgery for 
more than 9–12 months. It is attended with the risk of recurrent endometriosis and 
pelvic pain, which will make IVF more complicated.
In Malzoni et al. [14] publication, indications for radical colorectal surgery are 
described and clearly stated. Absolute indications are severe pain, bowel stenosis 
with functional organ compromise, and infertility in patients after unsuccessful 
IVF attempts even asymptomatic. The relative indications to radical surgery are the 
following: infertility in young patients (<35 years), infertility (even aged >35 years) 
after two or more IVF failures before the oocyte donation, and increased risks of 
pregnancy and delivery complications.
The last indication is one of the most disputable. Exacoustos et al. [15] described 
the obstetrical complication in patients with colorectal endometriosis. The number 
of premature delivery <37 weeks was five times more in colorectal endometriosis 
group than the control group. Placenta previa was diagnosed in every six patients 
with posterior endometriosis (only 1 case from 300 patients in control group). 
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Cesarian section was performed in 68.3% in colorectal endometriosis group. 
Hysterectomy, hemoperitoneum, bowel resection, and bladder injury were 
described in 3.6–7.1% of patients with colorectal endometriosis.
The pathogenic mechanisms of pregnancy complications can be the following: 
endometriosis-related chronic inflammation, adhesions and their mechanical 
implications, and invasion of decidualized ectopic endometrium to the vessel walls.
Taking into account the risks of surgical intervention in cases of DIE, it′s 
reasonable to perform the operation in the specialized medical centers by multidis-
ciplinary team, including gynecologist, urologist, colorectal surgeon, and fertility 
specialist. But endometriosis is a gynecological disease, and the gynecologist should 
be the leader of this team.
A very important practical question is what would be the recommendations if an 
unexperienced surgeon found DIE with diagnostic laparoscopy? In such case no one 
has repealed one of the basic rules of medical practice—“primum non nocere”—do 
not harm. If the surgeon is not enough experienced, to prevent complications, it 
would be better to stop the surgery after doing those steps, which could be done, 
according to the experience and send the patient to the clinic, which is focused on 
DIE treatment. Providing all the information about the presence of the disease to 
the patient is essential.
4. Endometrioma
In recent years, indications for surgical treatment of endometriomas in infertile 
patients are reconsidered due to the negative impact of surgery on the ovarian 
reserve, especially in recurrent cysts and bilateral localization. The surgeon faces 
the question which patients should be operated and if expectant management is 
chosen and then what period is appropriate. Comparative evaluation of cystectomy 
of non-endometriotic cyst (dermoid, serous, and mucinous cystadenoma) and 
Figure 2. 




endometriomas highlighted that some ovarian tissue was removed only in 6% dur-
ing surgical treatment of non-endometriotic cysts. In contrast, in the resection of 
endometriomas, ovarian tissue was present in the specimen in 54% of cases [1].
Nowadays, there is no consensus on the size of endometriomas which should 
be treated surgically. International recommendations indicate surgical treatment 
for cysts larger than 3–4 cm [3, 16] and according to some other guidelines, more 
than 6 cm.
According to some published data, surgery on the ovaries before IVF does not 
improve reproductive outcomes. The exception is large endometriomas which 
are difficult to puncture [17]. Asymptomatic endometriotic cysts of small size do 
not require surgical treatment, especially in patients older than 35 years. Surgical 
treatment must be performed in patients with long-term infertility in the presence 
of cysts greater than 4 cm [3].
In patients with a high risk of ovarian reserve damage (second ovarian surgery, 
bilateral localization, late reproductive age), it is necessary to consider cryopreser-
vation of embryos or vitrification of oocyte before surgical treatment.
Surgical treatment can be performed in three ways—aspiration, sclerotherapy, 
and laparoscopic/open removal. The endometriotic lining of endometrioma may 
undergo pressure atrophy, and that spontaneous resolution of cyst can be achieved 
by simple aspiration by ultrasound or laparoscopic control. In difficult cases (adhe-
sions, high risks of anesthesia, recurrence of small endometrioma), transvaginal 
puncture by ultrasound guidance could be recommended. According to differ-
ent publications, the recurrence rate for sclerotherapy is 9.1–66.7% and could be 
decreased to 12% by the use of 95% ethanol in situ [18]. However, this procedure 
has been associated with postoperative pelvic abscesses.
If the surgery is to be performed, then the “gold” standard in case of endome-
trioma and infertility is laparoscopic cystectomy. Cystectomy can be performed in 
two ways: cyst ablation and enucleation. Laparoscopic cystectomy demonstrates the 
best results in achieving pregnancy for the first identified unilateral endometrio-
mas. The spontaneous PR after cystectomy is more than 60%.
However, in the second surgery, partial capsule removal and ablation are the 
better options (to save ovarian reserve). In case of bilateral endometriomas in more 
advanced reproductive age and recurrent endometrioma, urgent IVF is indicated 
(the risk of decreased ovarian reserve). The removal of small endometrioma does not 
have an impact on cumulative PR. In some cases (recurrent endometrioma, difficulty 
in follicle puncture), sclerotherapy by ultrasound control could be recommended.
There are pitfalls of endometrioma’s surgery. Surgery should be performed in the 
follicular phase to prevent recurrence. High power electrosurgical technique should 
be avoided. Bipolar coagulation (max 30 Watts) and/or suturing of the ovarian 
tissue is safer. Ablation can be applied for recurrence endometrioma in particular. 
New energies (PlasmaJet, CO2 laser, argon-spread).
In our unpublished study, from 2010 to 2018, we performed 1187 laparoscopic 
procedures with removing of endometriomas in Moscow Regional Scientific 
Research Institute of Obstetrics and Gynecology. The average age of patients was 
31.6 years old. Among them we make a follow up in 530 patients, and only 259 were 
included in the study. From 259 patients 105 have primary infertility before surgery 
(40.5%), 45 (17.37%) have secondary infertility, and 93 (35.9%) did not desire a 
pregnancy. In total, infertility was detected in 150 cases (57.9%). Laparoscopy and 
cyst removal (stripping) were done in the majority of cases—211 (81.6%); in 48 
(18.4%) ovarium resection with the cyst was performed. Spontaneous pregnancy 
was registered among 77 women (51.3%). In 16 cases pregnancy was unexpected. 
Twenty-eight patients (18.6%) became pregnant after IVF. Cumulative pregnancy 
rate was 70% (105 patients). Ineffective attempts of spontaneous conception were 
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30, and IVF attempts were also unsuccessful in 36 cases (24%). After surgery, 
hormonal therapy was prescribed: dienogest in 34.3%, COC in 15%, and gonadotro-
pin-releasing hormone agonists (GnRH-a) in 1.9% cases. The recurrence rate of the 
disease was 13.1% (34 cases).
There are the risks of nonsurgical management of patients with cysts and infer-
tility [19]. The conditions with an expected high risk of complications, if patients go 
to IVF without surgical treatment, are the following: low ovarian responsiveness to 
the stimulation, low quality of oocytes, technical difficulties for ovarian puncture, 
endometrioma rupture, injury to adjacent organs, infection of the endometrioma, 
follicular fluid contamination, progression of endometriosis, pregnancy complica-
tions, the opportunity to miss the malignancy, and/or cancer development after IVF.
However, the meaning of surgery was overestimated. Surgical treatment did 
not improve an ovarian responsiveness to the stimulation, quality of oocytes, rate 
of technical difficulties during ovarian puncture, rate of injury to adjacent organs 
during this procedure, follicular fluid contamination, progression of endometriosis, 
and pregnancy complication rate.
5. Adenomyosis and infertility
Adenomyosis is a common gynecological disease, defined as the presence of 
ectopic endometrial epithelium and stroma in the myometrium.
Through the twentieth century before the widespread of transvaginal ultra-
sound (TVU) and magnetic resonance imaging (MRI) techniques, adenomyosis 
remained the disease, whose diagnosis was based on histological examination of the 
specimen after hysterectomy. As this examination was held after the surgery, the 
connection between infertility and adenomyosis was not well established. However, 
over the last three decades, the introduction of new diagnostic tools, mentioned 
above (TVU and MRI), made it possible to study adenomyosis without performing 
surgery. The measuring of the inner myometrium or myometrial junctional zone 
(JZ) described by Hricak group [21], provided new noninvasive diagnostic criteria 
for adenomyosis [22]. These new diagnostic tools allow us to diagnose the adenomy-
osis from early to advanced stages and see the progressing of the disease with high 
sensitivity and specificity. By different authors, the sensitivity and specificity range 
is 53–89% and 65–98% respectively. Although there is a great success in noninvasive 
diagnosis, the real incidence of adenomyosis is still unknown. The prevalence has 
been reported to range from 1 to 70%. This large range primarily reflects the lack of 
agreed diagnostic standards both by imaging tools and pathological analyses.
Even though many classifications, as well as scoring systems, have been pro-
posed since the first mentioning of endometriosis as a disease, no widespread 
agreement on a classification for endometriosis has been reached. Unfortunately, 
there is no ideal classification of endometriosis that would be able to reflect all the 
aspects of the disease, the pathogenesis, anatomical distribution, clinical manifesta-
tion, progression, and recurrence.
The clinical presentation of adenomyosis can vary from patient to patient, but 
the main symptoms are abnormal uterine bleeding and dysmenorrhea, occurring in 
approximately 65% of patients [23]. Today there is a strong data that there is a cor-
relation between the type, localization, and the number of endometriotic lesions and 
painful symptoms [24]. Despite the fact that the link between infertility and adeno-
myosis is still a subject of debate, the association between these two processes is clini-
cally recognized [25]. Infertility is found in 11–12% of patients with adenomyosis [26].
The effect of adenomyosis on fertility has been assessed by examining its preva-
lence in infertility in patients or its effect on the outcomes of assisted reproduction 
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technologies (ART). In a review by Campo et al. [27], several pathogenesis 
hypotheses of infertility in patients with adenomyosis are described. The first one 
was proposed by Kunz et al. [28, 29], which points out the idea of thickening and 
disruption of the myometrial JZ which can result in perturbed uterine peristalsis. In 
1984 Birnholz [30] has published his data about the presence of contraction waves 
in the myometrium: using transabdominal ultrasound, he showed that uterine 
peristaltic activity originates exclusively from the JZ, while the outer myometrium 
remains static. During the follicular and periovulatory phases, contraction waves 
have a cervico-fundal orientation, and their amplitude and frequency increase sig-
nificantly towards the time of ovulation. There is an idea that adenomyosis causes 
infertility by impairing sperm transport.
The second hypothesis is focused on biochemical and functional alterations in 
both eutopic and heterotopic endometrium in individuals with adenomyosis [31]. 
These alterations could lead to lower receptivity, as suggested by the presence of 
“implantation marker” defects. This increased knowledge has created new thera-
peutic options, including the block of local aromatase production through the use 
of selective estrogen receptor modulators, estrogen-progestin combinations, and 
gonadotropin-releasing hormone super agonists.
The third hypothesis proposes that the presence of an abnormal concentration 
of intrauterine free radicals [32] and of altered decidualization [33] is also sugges-
tive of altered receptivity. The authors propose that free radicals may adversely 
affect eggs and fertilized eggs in adenomyosis by a similar mechanism to that in 
endometriosis. The exaggerated expression of these enzymes suggests a crucial role 
of superoxide in infertility and/or miscarriage in these diseases.
A lot of studies showed the effect of adenomyosis on fertility in patients, who 
underwent ART. Recent reviews by Vercellini et al. [34] and Younes et al. [35] 
allowed to shed light on many questions, even though the number of publications 
analyzed in these reviews is small. In Vercellini review 1865 women were enrolled in 
the 9 selected studies, and in Younes paper only 15 studies were analyzed.
The prevalence of adenomyosis in the infertility population undergoing IVF/
ICSI varies widely, from 6.9% [36] to 34.3 [37]. A clinical pregnancy after IVF/
ICSI happens in 40.5% of women with adenomyosis and in 49.8% in those without 
this disease. The effect of adenomyosis on implantation rate per cycle is still con-
troversial, and different authors have different data, related to that topic [37, 38]. 
According to Piver’s publication [39], JZ thickness could be a predictive factor 
of repeated implantation failure in women who underwent IVF, suggesting that 
adenomyosis may impair embryo implantation in IVF cycles. As for the miscarriage 
rate, we now know that adenomyosis almost doubles this index: 31.9%, compared 
to 14.1% in women without adenomyosis. There could be also a connection between 
the miscarriage rate and a live birth rate per cycle. Martínez-Conejero et al. [37] 
reported 26.8% in the adenomyosis group and of 37.1% in the no adenomyosis group.
Despite the fact that now we have such meta-analysis data, it is still hard to 
understand the exact influence of the adenomyosis on the fertility, as in some 
analyzed studies there were groups of patients with both adenomyosis and endo-
metriosis, so it is difficult to identify whether IVF failure and early pregnancy 
complications were directly related to the presence of endometriosis or the presence 
of adenomyosis. However, Vercellini and his team concluded that adenomyosis has a 
negative effect on the outcome of IVF/ICSI, which leads to reduced rates of clinical 
pregnancy and implantation and an increased risk of early pregnancy loss. To sum 
up, it seems logical to screen for adenomyosis before starting assisted reproduction 
procedures [40].
Another publication shows that there is a heightened risk of preterm delivery 
in patients with adenomyosis. A case–control study of Juang et al. [41] reveals the 
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connection between adenomyosis and preterm birth, and two other studies show 
poor pregnancy and perinatal outcomes in adenomyosis patients [42, 47].
According to Sandberg’s study [43], the prevalence of adenomyosis in women 
in the time of delivery is quite high (17.8%), but complications during spon-
taneous pregnancy in such patients are rare. They can include rapid growth in 
pregnancy [44], spontaneous rupture of an unscarred uterus [45], and delayed 
postpartum hemorrhage [46]. Also, there is data that women with adenomyosis 
are at an increased risk of second-trimester miscarriage, small-for-gestational-
age, preeclampsia, fetal malpresentation, placental malposition, and postpar-
tum hemorrhage [47]. However, there are no large studies investigating the 
influence of adenomyosis on perinatal complications, and further accumulation 
of data is required to reveal this issue. Taking into account that the majority of 
pregnancies will be uneventful, it may be best that available information should 
be given to pregnant women in a way that would avoid raising unnecessary 
anxiety [40].
5.1 Fertily-sparing treatment
Treatment of adenomyosis could be conservative and surgical. Medical treat-
ment for adenomyosis follows the principles for medical treatment of endome-
triosis, which aim is to reduce the production of endogenic estrogen or induction 
of endometrial differentiation with progestins. The principles are inhibition 
of ovulation, abolition of menstruation, and establishment of a stable steroid 
milieu [48].
Nowadays there are several different options of conservative treatment, 
mainly against menstruation-related symptoms such as dysmenorrhea and heavy 
menstrual bleeding. According to Streuli et al. review [49], there are almost no 
well-conducted randomized controlled trials on the pharmacological treatment of 
adenomyosis, and the information collected from published studies is insufficient. 
However, experts’ opinion in this review says that the use of levonorgestrel-
releasing intrauterine system, oral contraceptive pills, and danazol can improve 
those symptoms. Also, there are very few reports showing therapeutic effects of 
these drugs for infertility. Despite the fact that there are many therapeutic options, 
the majority of them inhibits the ovulation and\or inducts of necrosis, which is 
unacceptable in infertile patients. So, in this chapter, we will discuss options, which 
could be applied in such a group of patients.
The use of gonadotropin-releasing hormone agonists (GnRH-a) and its effect on 
infertility were described in several studies. In two IVF studies [68] in which a long 
protocol GnRH-a was admitted, there were no lower pregnancy rates in women with 
adenomyosis. GnRH-a could be admitted in women with moderate to severe symp-
tomatic adenomyosis, especially in women with failed implantation of embryos of 
high quality. The weak point of these studies is that both of them were retrospec-
tive, and other factors may also have contributed. In patients with adenomyosis who 
plan to have frozen embryo transfer, one study [50] showed that 2-month GnRH 
analog pretreatment improved rates of implantation, clinical pregnancy, and ongo-
ing pregnancy.
There is also data that the treatment of an intrauterine device containing danazol 
resulted in the successful conception of infertile patients [51].
5.2 Surgical treatment
Grimbizis reviewed studies on uterus-sparing surgical treatment options for 
adenomyosis and concluded that this kind of treatment is feasible and efficient [52]. 
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There are several options nowadays: adenomyomectomy for diffuse or focal adeno-
myosis, cytoreductive surgery (partial adenomyomectomy), or a variety of non-
excisional techniques (endometrial ablation, high-intensity focused ultrasound 
(HIFU) and uterine artery embolization (UAE)). Non-excisional techniques result 
in tissue necrosis, which is unacceptable in patients who desires pregnancy.
In patients with adenomyosis who desires pregnancy, surgery should only be 
chosen if the medical treatment is no effect. In patients with the localized process 
(adenomyoma) it is possible to perform an adenomyomectomy and remove all 
pathologic tissue. Nowadays it is the most popular surgical technique, performed 
through the laparoscopic or open approach. Laparoscopic surgery (adenomyosis 
resection) might be proper for women younger than 40 years old with focal adeno-
myosis who failed infertility treatments including assisted reproductive technology 
[53]. Several kinds of incisions are proposed for such procedure—transverse, lon-
gitudinal, wedge-shaped, and transverse H-shaped incisions [54], which could be 
chosen according to the size and location of the lesion. As well as for the incisions, 
for suturing wounds, there are several different techniques, including double- and 
triple-flap methods [55, 56].
In Figure 3 you can see the different types of complete adenomyomectomy.
In patients with the diffuse process, cytoreductive surgery is performed. The 
main aim of the uterine preservation surgery is quite challenging—to remove the 
adenomyotic tissue as much as possible and to preserve the functional myometrium 
to save a functional uterus. In cases of diffuse process, it could be quite difficult to 
find the right plane and the border between those two layers in the adenomyotic 
uterus, as the pathologic tissue invades the myometrium. On one side of the scale, 
there is a radical treatment and on the other a functional uterus.
Figure 3. 
Different complete adenomyomectomy techniques. (A) Classic technique, (B) classic technique with 
overlapping flaps, and (C) triple-flap technique [52].
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In the recent review of fertility-sparing treatment for adenomyosis by Rocha 
et al. [57], there is also an analysis of combined medical and surgical treatment. 
The overall pooled clinical pregnancy rate after surgical resection of adenomyosis 
was 38.8%, ranging from 12.5 to 61.5%. The pooled miscarriage rate was 17.9% and 
pooled live birth rate 30.4%. As for spontaneous pregnancies, the overall clinical 
pregnancy rate was very low (18.2%). However, when using GnRH-a for 24 weeks 
after surgery [58, 59], the pooled spontaneous pregnancy rate was higher than 
not using adjuvant GnRH-a. There was no significant difference between pooled 
results with or without GnRH-a after adenomyomectomy for pregnancy rate, live 
birth rate, IVF pregnancy rate, or miscarriage rate. Two studies examined the effect 
of combined treatment with the use of adenomyomectomy and GnRH-a versus 
GnRH-a treatment alone [58, 60]. Even though the number of patients in the studies 
was small, it appears that surgery is associated with increased pregnancy rate. To 
sum up, adenomyomectomy alone has low spontaneous pregnancy rates and should 
be followed by ART or medical therapy with GnRH-a. Assisted reproductive tech-
nologies have good pregnancy rates in women with adenomyosis, and data suggest 
that long stimulation protocol is superior to short protocol. Most authors agree that 
there is currently no convincing evidence of the superiority of one of the methods 
of treatment over another and further prospective studies are needed to elucidate 
the usefulness of adenomyosis cytoreductive surgery as a fertility treatment. Also at 
the moment, literature data on such complications like uterine rupture and placenta 
accrete after surgery is scarce.
There is also a place for treatment adenomyosis with hysteroscopic techniques 
[61]. This method could be performed in patients with adenomyotic cysts, and 
crypts are suggested before treatment for fertility [62]. However, this procedure and 
its effect on adenomyosis are described only in case reports.
Dueholm et al. [48] in the recent review proposed an algorithm of how the 
patient with adenomyosis should be treated in infertility clinic. This algorithm is 
presented in Figure 4. However, authors make a conclusion that this algorithm is 
based on limited evidence and further randomized controlled trials are necessary to 
define the best strategy for patients with adenomyosis who want to conceive.
In the twenty-first century, new technologies come for patients suffering 
from uterine infertility, and without the option of surrogate motherhood, uterine 
Figure 4. 




Popov Alexander*, Koval Alexey, Fedorov Anton, Tyurina Svetlana, Fedotova Irina 
and Khabibullakh Tamana
Moscow Regional Research Institute of Obstetrics and Gynecology, Moscow, Russia
*Address all correspondence to: gyn_endoscopy@mail.ru
transplantation could be the only way to parenthood. Since the report in 2014 of a 
successful pregnancy [63] in the transplanted uterus, research interest in this field has 
been steadily growing with an increasing number of surgical teams training on the 
technique. Thirty-seven transplantations have already been realized worldwide set-
ting the stage for a complex new research area in gynecological surgery, which needs 
to address technical, ethical, social, and economic issues [64]. These new technologies 
in the nearest future could also give a chance to become a mother for patients with 
uterine infertility caused by adenomyosis, resistant to other types of treatment.
6. Summary
In spite of huge achievements both in reproductive surgery and assisted repro-
ductive technologies, endometriosis as a disease is very actual today. It is known that 
the number of ART centers has been increased recently, the majority of which do 
not have facilities to perform surgery. This fact seems quite controversial. It resulted 
in the situation when the importance of reproductive surgery is neglected. Most 
of the studies are originally oriented to a recognition of ART as a major method 
of infertility treatment. We think this practice leads to the loss of reproductive 
surgery quality and professional degradation. Spontaneous pregnancy rate occurs 
in 30–70% infertile patients after an adequate operation performed just in time. 
That means one- or two-thirds of patients with endometriosis-associated infertility 
do not need ART at all. However, surgery is not the only possible kind of infertility 
treatment. It is important to diminish the number of the second (third, fourth, etc.) 
surgery. The reproductologist should be involved in the treatment and ART could 
be recommended promptly. The best option is to find a balance between surgery 
and ART, which could be reached through the organization of the multidisciplinary 
team, “brother in arms” professional connections between the surgeon and the 
reproductologist. Only working together with a constant search of the best solution 
on how to reach the pregnancy and informing the infertile patient about all ways of 
the treatment could lead to success.
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